Biota Slumps on Merger Agreement With Nabi: Sydney Mover

Biota Holdings Ltd., an Australian company that earns royalties from influenza drugs, slumped in Sydney trading after agreeing to merge with Nabi Biopharmaceuticals to gain access to the Nasdaq market.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.